PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-327.96%
Negative net income growth while JD stands at 10.51%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-3.61%
Negative yoy D&A while JD is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
10.50%
Deferred tax of 10.50% while JD is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-10.50%
Negative yoy SBC while JD is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
133.52%
Working capital change of 133.52% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
-78.28%
AR is negative yoy while JD is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-108.09%
Negative yoy inventory while JD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
120.07%
AP growth of 120.07% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
139.93%
Growth of 139.93% while JD is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
107.17%
Some yoy increase while JD is negative at -301.39%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
150.05%
Some CFO growth while JD is negative at -173.37%. John Neff would note a short-term liquidity lead over the competitor.
-11.68%
Negative yoy CapEx while JD is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-32.46%
Negative yoy acquisition while JD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
53.12%
Purchases growth of 53.12% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
67.53%
Liquidation growth of 67.53% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
32.46%
Less 'other investing' outflow yoy vs. JD's 248.67%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
866.28%
Investing outflow well above JD's 230.06%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-8621.45%
We cut debt repayment yoy while JD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
37.57%
Issuance growth of 37.57% while JD is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.